Jay Jaiswal
Internal Medicine · Philadelphia, PANPI 1417527276
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 90.5% of the total across 67 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 23.9% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,618, more than ten times the $42 reported in 2023.
Across 67 payments — averaging $30.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kestra Medical Technology Services, Inc.$493
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$250
- Pfizer$206
- Medtronic$180
- Abbott$144
- Novo Nordisk$117
- plus $677 from 16 others
What the payments were for
- Food & beverage$1,87291%
- Education$1969%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kestra Medical Technology Services, Inc. | 15 | $493 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 11 | $250 |
| Pfizer | 7 | $206 |
| Medtronic | 2 | $180 |
| Abbott | 1 | $144 |
| Novo Nordisk | 1 | $117 |
| Abiomed | 2 | $113 |
| Merck | 6 | $101 |
| AstraZeneca | 3 | $61 |
| Amgen | 3 | $51 |
| Stryker | 1 | $50 |
| Edwards Lifesciences | 2 | $48 |
| Alnylam Pharmaceuticals Inc. | 2 | $38 |
| Bridgebio Pharma, Inc. | 2 | $35 |
| Boston Scientific | 1 | $30 |
| Novartis | 2 | $27 |
| Heartflow, Inc. | 1 | $27 |
| Lilly USA, LLC | 1 | $23 |
| Irhythm Technologies, Inc. | 1 | $21 |
| Exact Sciences | 1 | $19 |
| Fresenius Kabi USA, LLC | 1 | $19 |
| Bayer | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENSITE$144
- Ozempic$117
- VYNDAQEL$114
- COREVALVE EVOLUT R$113
How this compares
$2,068 in reported general payments places this provider in the 80th percentile of 5,705 internal medicine providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 12 | $157 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Philadelphia
- Jonathan EpsteinPhiladelphia$13.1M
- Pitamber DevgonPhiladelphia$7.5M
- Daniel RaderPhiladelphia$1.7M
- David GoldmannPhiladelphia$525K
- Eyob FeyssaPhiladelphia$328K
- Emil AbramianPhiladelphia$199K
- Michael KnightPhiladelphia$178K
- James BlakePhiladelphia$164K
- Gina SimonciniPhiladelphia$158K
- James LewisPhiladelphia$106K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.